Proton-Pump Inhibitor as Palliative Care for Chemotherapy-Induced Gastroesophageal Reflux Disease in Pancreatic Cancer Patients

被引：11

作者：

Uwagawa, Tadashi ^{[1
]}

Misawa, Takeyuki ^{[1
]}

Iida, Tomonori ^{[1
]}

Sakamoto, Taro ^{[1
]}

Gocho, Takeshi ^{[1
]}

Wakiyama, Shigeki ^{[1
]}

Hirohara, Shoichi ^{[1
]}

Yanaga, Katsuhiko ^{[1
]}

机构：

[1] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan

来源：

JOURNAL OF PALLIATIVE MEDICINE | 2010年 / 13卷 / 07期

关键词：

RECOMMENDATIONS; GUIDELINES; THERAPY;

D O I：

10.1089/jpm.2009.0404

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Relief of adverse events induced by chemotherapy is an important issue for patients, especially those with a poor prognosis, such as with pancreatic cancer. There are no reports of the relationship between gastroesophageal reflux disease (GERD) and chemotherapy, so we investigated the incidence of chemotherapy-induced GERD in patients undergoing treatment with gemcitabine or S-1 for pancreatic cancer and the effect of sodium rabeprazole (RPZ), a proton-pump inhibitor. GERD was diagnosed in 40% of the patients according to the Frequency Scale for Symptoms of GERD score, and RBZ therapy significantly improved their symptoms.

引用

页码：815 / 818

页数：4

共 50 条

[31] Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor
Oda, K
Iwakiri, R
Hara, M
Watanabe, K
Danjo, A
Shimoda, R
Kikkawa, A
Ootani, A
Sakata, H
Tsunada, S
Fujimoto, K
DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (10) : 1921 - 1926
[32] Overview of pediatric gastroesophageal reflux disease and proton pump inhibitor therapy
Colletti, RB
Di Lorenzo, C
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2003, 37 : S7 - S11
[33] Dysphagia Associated with Gastroesophageal Reflux Disease Is Improved by Proton Pump Inhibitor
Kayoko Oda
Ryuichi Iwakiri
Megumi Hara
Kazuyo Watanabe
Akiko Danjo
Ryo Shimoda
Atsushi Kikkawa
Akifumi Ootani
Hiroyuki Sakata
Seiji Tsunada
Kazuma Fujimoto
Digestive Diseases and Sciences, 2005, 50 : 1921 - 1926
[34] Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited DISCUSSION
Melvin, W. Scott
Lada, Michal
Ferri, Lorenzo
Brunt, L. Michael
SURGERY, 2013, 154 (04) : 864 - 866
[35] The Impact of Proton Pump Inhibitor Compliance on Health-Care Resource Utilization and Costs in Patients with Gastroesophageal Reflux Disease
Gosselin, Antoine
Luo, Roger
Lohoues, Herve
Toy, Edmond
Lewis, Barbara
Crawley, Joseph
Duh, Mei Sheng
VALUE IN HEALTH, 2009, 12 (01) : 34 - 39
[36] Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
de Sa, Claudia Cristina
Kishi, Humberto Setsuo
Silva-Werneck, Ana Luiza
Pinto de Moraes-Filho, Joaquim Prado
Eisig, Jaime Natan
Barbuti, Ricardo Correa
Hashimoto, Claudio Lyioti
Navarro-Rodriguez, Tomas
CLINICS, 2011, 66 (04) : 557 - 561
[37] A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease
Shimizu, Yasuo
Dobashi, Kunio
Kobayashi, Setsuo
Ohki, Ichiro
Tokushima, Masahiko
Kusano, Motoyasu
Kawamura, Osamu
Shimoyama, Yasuyuki
Utsugi, Mitsuyoshi
Sunaga, Noriaki
Ishizuka, Tamotsu
Mori, Masatomo
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 209 (03): : 181 - 189
[38] Characteristics of Patients Initiating a New Proton Pump Inhibitor for Treatment of Gastroesophageal Reflux Disease (GERD)
Gerson, Lauren
Mody, Reema
Eisenberg, Debra
Hou, Likun
Kamat, Siddhesh
Singer, Joseph
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S398 - S398
[39] The Effect of Proton Pump Inhibitor for Lung Function in Patients With Bronchial Asthma and Gastroesophageal Reflux Disease
Lee, Chang Min
Lee, Dong Ho
Yoon, Hyuk
Shin, Cheol Min
Park, Young Soo
Kim, Nayoung
GASTROENTEROLOGY, 2016, 150 (04) : S270 - S270
[40] Cost-effective management of gastroesophageal reflux disease: Is there a role for switching proton-pump inhibitors?
Inadomi, JM
Dodd, SL
GASTROENTEROLOGY, 2005, 128 (04) : A526 - A526

← 1 2 3 4 5 →